Clinical Trials Browser

Phase 2/3 × NSCLC × Gefitinib × Clear all

NCT00259064 2016-06-02

INSTEP

Phase 2/3 Completed

NSCLC

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Phase 2/3 Unknown

NSCLC